Sotalol
Sponsors
Region Oerebro Laen, Helsinki University Central Hospital, Národny ustav srdcovych a cievnych chorob a.s., University Of Pecs, Gottsegen National Cardiovascular Center, Assistance Publique Hopitaux De Paris, University of Washington, University of Utah, National Heart, Lung, and Blood Institute (NHLBI)
Conditions
ArrhythmiaAsymptomatic Patients with frequent PVCs and normal LVEFAtrial FibrillationBioequivalenceCardiovascular DiseasesCerebrovascular AccidentDeath, SuddenDeath, Sudden, Cardiac
Phase 1
Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers
TerminatedNCT02153437
Start: 2014-10-30End: 2016-10-20Updated: 2023-12-19
Bioequivalence Study of Sotalol, Tablets, 160 mg (Pharmtechnology LLC, Belarus), and Sotalex ®, Tablets, 160 mg (Bristol-Myers Squibb GmbH & Co. KGaA, Germany), in Healthy Volunteers Under Fasting Conditions
CompletedNCT03799536
Start: 2019-01-09End: 2019-02-11Updated: 2019-06-07
Phase 3
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
CompletedNCT00000464
Start: 1987-04-30Updated: 2013-07-29
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
CompletedNCT00000556
Start: 1995-03-31End: 2002-09-30Updated: 2016-03-25
Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
CompletedNCT00000518
Start: 1985-07-31End: 1992-12-31Updated: 2016-01-21
Antiarrhythmics Versus Implantable Defibrillators (AVID)
CompletedNCT00000531
Start: 1992-09-30End: 2002-08-31Updated: 2016-04-14
Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm
CompletedNCT00007605
Start: 1998-04-30End: 2003-12-31Target: 706Updated: 2011-06-15
Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.
CompletedNCT00035451
Start: 2001-02-28End: 2003-06-30Updated: 2011-10-03
First-line cryoablation for early treatment of Persistent Atrial Fibrillation – a randomized study comparing early trigger isolation using the Cryoballoon versus antiarrhythmic medication
RecruitingCTIS2023-505962-28-00
Start: 2024-05-08Target: 256Updated: 2025-09-29
SUPPRESS. Prophylactic frequent premature ventricular complexeS sUPPression on left ventriculaR function impairmEnt in aSymptomatic patientS
RecruitingCTIS2024-516372-14-00
Start: 2025-01-13Target: 298Updated: 2024-09-18
Phase 4
Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation
NCT02145546
Start: 2014-05-31End: 2017-05-31Target: 600Updated: 2014-05-23
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
RecruitingNCT02347111
Start: 2020-12-31End: 2026-06-30Target: 162Updated: 2025-08-24
Efficacy and Safety of Sotalol in Children With Arrhythmia
NCT03895411
Start: 2019-08-31End: 2022-12-31Target: 500Updated: 2019-03-29
Unknown Phase
Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator
TerminatedNCT01576042
Start: 2012-05-31End: 2014-05-31Updated: 2014-10-16
Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)
NCT02294955
Start: 2008-05-31End: 2018-09-30Updated: 2017-05-09
Elimination of VPB With Ablation Versus Anti-arrhythmic Drug Treatment
CompletedNCT03845010
Start: 2019-02-12End: 2023-01-17Updated: 2023-06-28
Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients
CompletedNCT04128878
Start: 2019-05-01End: 2020-12-31Updated: 2021-01-14
Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation
CompletedNCT05279833
Start: 2021-09-24End: 2022-03-31Updated: 2024-01-09